This bill protects healthcare providers and individuals from civil and criminal liability when they distribute or use Naloxone and other opioid reversal drugs even after their labeled expiration dates have passed. It allows people acting in good faith to administer these medications to someone believed to be having an opioid overdose without fear of legal consequences, except in cases of gross negligence or intentional misconduct. Healthcare professionals are also shielded from disciplinary action by licensing boards for actions covered under this immunity, though federally certified facilities must still follow federal rules regarding expired medications. The law defines "shelf-life end date" based on federal labeling requirements and takes effect upon the governor's signature.
This bill requires health insurance companies in Louisiana to cover mobile crisis response and behavioral health crisis care services when provided by eligible licensed providers. The law mandates that these services do not need prior authorization from insurers and allows providers to coordinate with the state's Crisis Hub for information sharing. Coverage may include standard cost-sharing options like deductibles and copayments, while reimbursement methods remain up to each insurer's discretion. The bill defines these services as short-term, recovery-focused interventions for adults and children experiencing mental health or substance use crises, with an effective date of July 1, 2027.
HB 404 establishes a medication-assisted treatment (MAT) program for incarcerated individuals in Louisiana state and local correctional facilities who have substance abuse disorders. The bill requires facilities to provide FDA-approved medications (like methadone or buprenorphine), individual treatment plans, counseling, and reentry support - including Medicaid enrollment assistance, housing/employment resources, and a one-week medication supply upon release. It mandates annual reporting on program effectiveness, including recidivism and health outcomes, and prohibits denying program access based on drug screenings or past disciplinary issues. The program directly affects all incarcerated people in Louisiana facilities with substance use disorders, aiming to improve treatment continuity and reduce relapse post-release.
HB 211 creates Louisiana's "Homelessness Court Program," establishing specialized court divisions to address homelessness through treatment and support instead of incarceration. It directly affects individuals experiencing homelessness charged with misdemeanors or felonies related to public camping or survival needs, requiring courts to screen eligible defendants for the program. Key provisions include mandatory substance abuse and mental health treatment, housing/job assistance partnerships, and a new criminal penalty for "unauthorized camping on public property" (with exceptions for shelter access). The program aims to reduce recidivism, court workloads, and prison overcrowding by integrating health care, housing, and rehabilitation services under judicial supervision.
HB 760 prohibits Louisiana Medicaid-enrolled healthcare providers from charging patients extra fees or co-payments for covered services related to medication-assisted treatment for substance use disorders. The bill requires providers to accept the Medicaid program’s payment as full payment for these services, eliminating unauthorized charges. Violations could lead to the provider’s termination or exclusion from Medicaid for up to one year. This directly affects Medicaid providers and patients receiving medication-assisted treatment, ensuring no out-of-pocket costs for these specific covered services.
SB 43 establishes Louisiana's Psychedelic-Assisted Therapy Program within the Department of Health to fund clinical studies using psychedelic medications (like psilocybin) for treating opioid use disorders, co-occurring substance use disorders, and treatment-resistant mental health conditions. The program requires academic health centers to meet strict federal and state compliance standards - including FDA approval, safety protocols, and therapist qualifications - to conduct these studies. Eligible patients, including those with the specified conditions, may participate, and parishes can use opioid settlement funds to enroll residents. The bill mandates annual progress reports from participating centers and requires coordination with other states conducting similar research. This is a research-focused program, not a policy allowing general therapeutic use.
HB 823 establishes a pilot program in Orleans Parish that offers homeless individuals facing criminal charges an alternative to court proceedings. Instead of traditional sentencing, eligible defendants can participate in a diversion program providing housing assistance, mental health services, job training, and substance abuse treatment. If participants successfully complete the program’s requirements, the criminal charges are dismissed without a conviction. The program requires annual evaluations and reporting to the Louisiana Supreme Court, aiming to reduce recidivism, court workload, and prison overcrowding while addressing homelessness through community partnerships.
HB 676 prohibits paying or receiving money for referring patients to substance abuse, mental health, or substance use disorder treatment facilities, defining this practice as "body brokering." It bans kickbacks tied to referral volume, treatment duration, or service type, but allows fixed payments unrelated to these factors. Violators face up to 5 years in prison, $50,000 fines, license suspension, or civil penalties. The law directly affects health care providers, facilities, and entities involved in patient referrals for substance use disorder treatment.
SB 168 amends Louisiana's regulatory framework for addiction counseling by defining key terms and establishing new credentialing pathways for peer support specialists. It creates specific roles like "peer support specialist associates" and "supervisors," outlines their scope of practice (non-clinical support based on lived experience), and clarifies that peer services complement, but do not replace, clinical treatment. The bill also defines "addictive disorder," "behavioral health condition," and "core functions" (e.g., screening, assessment, case management) for addiction counselors. This procedural bill focuses on regulatory structure rather than direct service changes and is currently pending referral to the Health and Welfare Committee.
SB 26 repeals two Louisiana statutes (R.S. 40:2116(B)(5) and 2159) that required facility need reviews for opioid treatment programs. This bill directly affects opioid treatment facilities in Louisiana by removing a specific administrative review requirement. The key change is eliminating the need for these facilities to undergo a separate review process before operating, streamlining their regulatory compliance under state law.
